More importantly, DMC1 interacts directly with the DNA repair gene BRCA2, which may provide possibilities for synthetic lethality targets for ovarian cancer (Harada et al., 2001; Martinez et al., 2016). This evidence concerns the gene BRCA2 and ovarian cancer.